UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 20.1% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,393,951 shares of the medical equipment provider's stock after acquiring an additional 566,979 shares during the quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned about 0.95% of Intuitive Surgical worth $1,680,922,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of ISRG. Woodline Partners LP raised its holdings in shares of Intuitive Surgical by 35.3% during the first quarter. Woodline Partners LP now owns 112,172 shares of the medical equipment provider's stock worth $55,555,000 after acquiring an additional 29,283 shares during the period. MBB Public Markets I LLC acquired a new position in shares of Intuitive Surgical during the 1st quarter worth about $318,000. Ascent Group LLC lifted its position in shares of Intuitive Surgical by 4.9% in the first quarter. Ascent Group LLC now owns 6,102 shares of the medical equipment provider's stock valued at $3,022,000 after buying an additional 284 shares during the last quarter. United Services Automobile Association acquired a new position in shares of Intuitive Surgical in the first quarter valued at $4,039,000. Finally, Arete Wealth Advisors LLC boosted its holdings in shares of Intuitive Surgical by 14.8% during the 1st quarter. Arete Wealth Advisors LLC now owns 2,191 shares of the medical equipment provider's stock worth $1,086,000 after buying an additional 283 shares during the period. 83.64% of the stock is owned by institutional investors.
Intuitive Surgical Price Performance
ISRG stock traded down $6.17 during trading on Friday, reaching $449.68. 2,218,377 shares of the company were exchanged, compared to its average volume of 2,025,311. The company has a 50-day moving average of $487.55 and a two-hundred day moving average of $509.57. The company has a market capitalization of $161.20 billion, a price-to-earnings ratio of 62.72, a P/E/G ratio of 4.72 and a beta of 1.61. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to analysts' expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm's quarterly revenue was up 21.4% compared to the same quarter last year. During the same period in the prior year, the company earned $1.78 EPS. On average, analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.
Insider Buying and Selling
In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of the company's stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the transaction, the insider directly owned 19,827 shares in the company, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Amy L. Ladd sold 336 shares of the company's stock in a transaction that occurred on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the transaction, the director owned 1,074 shares of the company's stock, valued at approximately $504,898.14. This trade represents a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 45,224 shares of company stock worth $21,716,492 in the last three months. 0.70% of the stock is owned by corporate insiders.
Analyst Ratings Changes
A number of research analysts recently commented on ISRG shares. Deutsche Bank Aktiengesellschaft reiterated a "sell" rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Piper Sandler reissued an "overweight" rating and issued a $595.00 price objective (up previously from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Royal Bank Of Canada reissued an "outperform" rating and issued a $615.00 price objective on shares of Intuitive Surgical in a report on Tuesday, August 19th. Citigroup reissued a "buy" rating and issued a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Finally, BTIG Research boosted their price objective on shares of Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a report on Wednesday, July 23rd. Thirteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Intuitive Surgical has a consensus rating of "Moderate Buy" and an average target price of $595.95.
Check Out Our Latest Stock Report on Intuitive Surgical
About Intuitive Surgical
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.